Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

被引：0
|
作者：
Douglas E Faries
Haya Ascher-Svanum
Allen W Nyhuis
Bruce J Kinon
机构：
[1] US Statistics,US Outcomes Research
[2] Eli Lilly and Company,Psychosis Medical
[3] Eli Lilly and Company,undefined
[4] LLC,undefined
来源：
BMC Psychiatry | / 9卷
关键词：
Risperidone; Olanzapine; Propensity Score; Antipsychotic Medication; Brief Psychiatric Rate Scale;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
    Faries, Douglas E.
    Ascher-Svanum, Haya
    Nyhuis, Allen W.
    Kinon, Bruce J.
    [J]. BMC PSYCHIATRY, 2009, 9
  • [2] Ramifications of switching antipsychotics in the treatment of schizophrenia
    Faries, D
    Ascher-Svanum, H
    Nyhuis, AW
    Kinon, BJ
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 29S - 29S
  • [3] Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia
    Ascher-Svanum, Haya
    Nyhuis, Allen W.
    Faries, Douglas E.
    Kinon, Bruce J.
    Baker, Robert W.
    Shekhar, Anantha
    [J]. SCHIZOPHRENIA BULLETIN, 2008, 34 (06) : 1163 - 1171
  • [4] Functional, clinical, and economic ramifications of early non-response to antipsychotics in the naturalistic treatment of schizophrenia
    Nyhuis, A.
    Ascher-Svanum, H.
    Faries, D.
    Kinon, B. J.
    Baker, R. W.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 488 - 488
  • [5] Predictors of switching antipsychotics in the treatment of schizophrenia
    Thomas, NA
    Nyhuis, AW
    Faries, D
    Ascher-Svanum, H
    Kinon, BJ
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A77 - A77
  • [6] Predictors of switching antipsychotics in the treatment of schizophrenia
    Nyhuis, AW
    Faries, DE
    Ascher- Svanum, H
    Kinon, BJ
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 27S - 28S
  • [7] An economic comparison of antipsychotics in treatment of schizophrenia
    Sorensen, SV
    Russell, JM
    Mackell, JA
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 354 - 354
  • [8] One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
    Edwards, Natalie C.
    Pesa, Jacqueline
    Meletiche, Dennis M.
    Engelhart, Luella
    Thompson, Ann K.
    Sherr, Jay
    Dirani, Riad
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3341 - 3355
  • [9] ECONOMIC EVALUATION OF ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW
    Santos, A. S.
    Godoi, I. P.
    Brandao, C. M.
    Vidal, C. L.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A194 - A195
  • [10] Monotherapy with atypical antipsychotics for schizophrenia: A clinical review and economic evaluation of first twelve months of treatment
    Farahati, F.
    Boucher, M.
    Williams, R.
    Moulton, K.
    Herrmann, N.
    Normandin, S.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A114 - A114
12345